Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma.

Khan AA, Jabeen M, Khan AA, Owais M.

Nanomedicine (Lond). 2013 Aug;8(8):1281-94. doi: 10.2217/nnm.12.166. Epub 2013 Jan 14.

PMID:
23311988
[PubMed - indexed for MEDLINE]
2.

Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.

Zheng S, Chang S, Lu J, Chen Z, Xie L, Nie Y, He B, Zou S, Gu Z.

PLoS One. 2011;6(6):e21064. doi: 10.1371/journal.pone.0021064. Epub 2011 Jun 9.

PMID:
21695227
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.

Zhao J, Chen X, Lin W, Wu G, Zhuang Q, Zhong X, Hong Z, Peng J.

Int J Oncol. 2013 Mar;42(3):971-8. doi: 10.3892/ijo.2013.1779. Epub 2013 Jan 18.

PMID:
23338043
[PubMed - indexed for MEDLINE]
4.

Anticancer potential of aqueous extract of alocasia macrorrhiza against hepatic cancer in vitro and in vivo.

Fang S, Lin C, Zhang Q, Wang L, Lin P, Zhang J, Wang X.

J Ethnopharmacol. 2012 Jun 14;141(3):947-56. doi: 10.1016/j.jep.2012.03.037. Epub 2012 Mar 28.

PMID:
22472110
[PubMed - indexed for MEDLINE]
5.

Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.

Lu XL, Zeng J, Chen YL, He PM, Wen MX, Ren MD, Hu YN, Lu GF, He SΧ.

Int J Oncol. 2013 Jan;42(1):229-38. doi: 10.3892/ijo.2012.1704. Epub 2012 Nov 16.

PMID:
23165705
[PubMed - indexed for MEDLINE]
6.

5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model.

Cheng M, He B, Wan T, Zhu W, Han J, Zha B, Chen H, Yang F, Li Q, Wang W, Xu H, Ye T.

PLoS One. 2012;7(10):e47115. doi: 10.1371/journal.pone.0047115. Epub 2012 Oct 15.

PMID:
23077553
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes.

Yang Y, Yang L, You QD, Nie FF, Gu HY, Zhao L, Wang XT, Guo QL.

Cancer Lett. 2007 Oct 28;256(2):259-66. Epub 2007 Aug 10.

PMID:
17693016
[PubMed - indexed for MEDLINE]
8.

Growth inhibition and apoptosis induction by (+)-Cyanidan-3-ol in hepatocellular carcinoma.

Monga J, Pandit S, Chauhan RS, Chauhan CS, Chauhan SS, Sharma M.

PLoS One. 2013 Jul 24;8(7):e68710. doi: 10.1371/journal.pone.0068710. Print 2013.

PMID:
23894334
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells.

Simbula G, Columbano A, Ledda-Columbano GM, Sanna L, Deidda M, Diana A, Pibiri M.

Apoptosis. 2007 Jan;12(1):113-23.

PMID:
17136495
[PubMed - indexed for MEDLINE]
10.

Livistona chinensis seed suppresses hepatocellular carcinoma growth through promotion of mitochondrial-dependent apoptosis.

Lin W, Zhao J, Cao Z, Zhuang Q, Zheng L, Cai Q, Chen D, Wang L, Hong Z, Peng J.

Oncol Rep. 2013 May;29(5):1859-66. doi: 10.3892/or.2013.2319. Epub 2013 Mar 1.

PMID:
23467659
[PubMed - indexed for MEDLINE]
11.

HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.

Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS.

Cancer Lett. 2012 Mar 28;316(2):187-95. doi: 10.1016/j.canlet.2011.10.037. Epub 2011 Nov 4.

PMID:
22182943
[PubMed - indexed for MEDLINE]
12.

Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.

Zhou Q, Ching AK, Leung WK, Szeto CY, Ho SM, Chan PK, Yuan YF, Lai PB, Yeo W, Wong N.

Int J Oncol. 2011 Mar;38(3):721-31. doi: 10.3892/ijo.2011.902. Epub 2011 Jan 14.

PMID:
21240457
[PubMed - indexed for MEDLINE]
13.

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.

BMC Cancer. 2012 May 4;12:166. doi: 10.1186/1471-2407-12-166.

PMID:
22559167
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.

Duan J, Zhang Y, Han S, Chen Y, Li B, Liao M, Chen W, Deng X, Zhao J, Huang B.

Int J Pharm. 2010 Nov 15;400(1-2):211-20. doi: 10.1016/j.ijpharm.2010.08.033. Epub 2010 Sep 8.

PMID:
20813175
[PubMed - indexed for MEDLINE]
15.

Inhibition of human hepatocellular carcinoma by L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vitro and in vivo.

Hu QY, Li JN, Song DQ, Wang YL, Bekesi G, Weisz I, Jiang JD.

Int J Oncol. 2004 Nov;25(5):1289-96.

PMID:
15492817
[PubMed - indexed for MEDLINE]
16.

Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.

Rajasekaran D, Elavarasan J, Sivalingam M, Ganapathy E, Kumar A, Kalpana K, Sakthisekaran D.

Mol Med Rep. 2011 Nov-Dec;4(6):1211-7. doi: 10.3892/mmr.2011.555. Epub 2011 Aug 16.

PMID:
21850372
[PubMed - indexed for MEDLINE]
17.

Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.

Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.

Carcinogenesis. 2013 Jun;34(6):1323-30. doi: 10.1093/carcin/bgt058. Epub 2013 Feb 12.

PMID:
23404993
[PubMed - indexed for MEDLINE]
Free Article
18.

IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma.

Lee JH, Lee H, Yun SM, Jung KH, Jeong Y, Yan HH, Hong S, Hong SS.

Cancer Lett. 2013 Feb 1;329(1):99-108. doi: 10.1016/j.canlet.2012.10.028. Epub 2012 Nov 8.

PMID:
23142281
[PubMed - indexed for MEDLINE]
19.

Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.

Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, Xing YY, Xi T.

Anticancer Drugs. 2009 Apr;20(4):249-58. doi: 10.1097/CAD.0b013e328327d476.

PMID:
19174695
[PubMed - indexed for MEDLINE]
20.

Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.

Zhao Z, He M, Yin L, Bao J, Shi L, Wang B, Tang C, Yin C.

Biomacromolecules. 2009 Mar 9;10(3):565-72. doi: 10.1021/bm801225m.

PMID:
19175304
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk